<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9D7015D3-F2EE-429B-8EC5-D42600C6391B"><gtr:id>9D7015D3-F2EE-429B-8EC5-D42600C6391B</gtr:id><gtr:firstName>Maryse</gtr:firstName><gtr:surname>Bailly</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/3D19057C-3272-4744-A525-0BE840DF3BAC"><gtr:id>3D19057C-3272-4744-A525-0BE840DF3BAC</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Treisman</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B8B460BB-2C6E-41DD-B963-764DFE9F5171"><gtr:id>B8B460BB-2C6E-41DD-B963-764DFE9F5171</gtr:id><gtr:firstName>Peng Tee</gtr:firstName><gtr:surname>Khaw</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0500927"><gtr:id>A2331EAE-5C95-486F-9EBC-E373AF45F48B</gtr:id><gtr:title>Molecular mechanisms of cell responses to mechanical stress through modulation of actin dynamics</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0500927</gtr:grantReference><gtr:abstractText>Cells in the body are under constant tension within the various tissues to maintain organ integrity and function. Modification of the local force equilibrium through direct stretch or pressure regulates cell differentiation and behaviour. However, uncontrolled mechanical stress is also linked to a large number of ailments ranging from abnormal wound healing, scarring and fibrosis, to pathologies associated with stress-prone organs such as the cardiovascular system, cartilage or the eye. In the eye only, scarring accounts for the pathogenesis or failure of treatment of virtually all blinding diseases, and differential response to mechanical stress may underpin susceptibility to blindness in glaucoma patients. As these complex interactions are being unravelled, the basic mechanisms that govern the response to mechanical stress remain largely unknown. Some of our earlier work suggested that the cells? response to the stress is linked to the state of their actin cytoskeleton, a dynamic network of cables that constitutes the internal cell scaffolding. This project aims at characterizing the mechanisms involved in the cell?s sensing and response to mechanical stress, and identify novel targets to control and modulate wound healing and tissue contraction, ultimately providing the basis for the development of improved regeneration-based therapies in ocular scarring.</gtr:abstractText><gtr:technicalSummary>Mechanical stress is believed to be an essential component of wound healing and its associated pathologies such as scarring processes and fibrosis, as well as in pathologies associated with stress-prone organs such as the cardiovascular system, cartilage or the eye. With the recent advances in stem cell research, tissue engineering and regenerative medicine, there is also a growing body of evidence suggesting that mechanical stimulation of cells and/or re-creation of the 3D-mechanical constraints are essential for proper cell differentiation and behaviour. As these complex interactions are being unravelled, the basic mechanisms that govern response to mechanical stress in 3 dimensions remain largely unknown. Using a unique device that allows us to study mechanical stress in cells within a 3D environment, this project propose to investigate the hypothesis that mechanical stress sensing and celullar responses to mechanical stress, especially in terms of acquisition of a contractile behaviour, are linked to the modulation of actin dynamics and specific activation of the transcription factor SRF through its co-activator MAL. Testing the links between mechanical stress and cell behaviour in the context of tissue contraction, this project will use a combination of qualitative and quantitative 3D and 4D image analysis to determine the nature if the relationship between the dynamics of the actin cytoskeleton and the response to mechanical stress, especially in terms of SRF activation. These studies should prove not only essential to the fundamental understanding of the molecular basis of cellular responses to mechanical stress, but will also identify novel targets to control and modulate wound healing and tissue contraction, and ultimately lead to novel therapies for tissue repair and regeneration.</gtr:technicalSummary><gtr:fund><gtr:end>2009-04-23</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-24</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>249403</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cancer Research UK London Research Institute (LRI)</gtr:department><gtr:description>MAL/SRF and mechanoregulation in 3D</gtr:description><gtr:id>C94DCB15-CD34-4B56-99BE-454877A90CF0</gtr:id><gtr:impact>Paper in Embo Reports (McGee et al 2011)
UCL BRCs - Francis Crick Institute Clinical Research Training Fellowship. &amp;quot;The MRTF-A/SRF transcription pathway as a novel target to prevent scarring in the eye&amp;quot;. Awarded to Cynthia Yu-Wai-Man. Co-supervisors Bailly, M, Khaw PT, and Treisman, R. Start date October 2013, 36 months, &amp;pound; 120,000.
Review in IOVS (Yu-Wai-Man et al, 2014)</gtr:impact><gtr:outcomeId>YUJMAASdGme-1</gtr:outcomeId><gtr:partnerContribution>transfer of reagents and further grant application</gtr:partnerContribution><gtr:piContribution>Our collaborator provided reagents and expertise as well as advice</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>TED patient information day</gtr:description><gtr:form>A formal working group, expert panel or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>93964F24-01C7-4893-8277-C6C2752C9394</gtr:id><gtr:impact>This was the first Patient and Public Involvement day for TED and it was well attended (over 100 patients and family). The day received very positive feedback, and achieved its key objective - namely to encourage patient engagement with researchers in identifying priorities and improving trial design. An invaluable insight was gained into patients' needs for a better quality-of-life.

An invaluable insight was gained into patients' needs for a better quality-of-life.
Of 100 attendees, 70 completed questionnaires (35 patients, 9 supporters, 4 exhibitors, 15 healthcare professionals, and 7 'others'). When asked whether the day had provided what they wanted, 48/52 (92%) said &amp;quot;yes&amp;quot;, 3/52 (6%) said &amp;quot;no&amp;quot;. Overall 6/52 (12%) rated it &amp;quot;good&amp;quot;, 28/52 (54%) &amp;quot;very good&amp;quot;, and 18/52 (34%) &amp;quot;excellent&amp;quot;. Thirty-six patients registered to participate in further research and identified &amp;quot;finding the cause for TED&amp;quot;, &amp;quot;improving psychological support&amp;quot;, and &amp;quot;achieving a better cosmetic outcome&amp;quot;, as key priorities for future research. A poor understanding of TED amongst medical professionals was a common complaint.</gtr:impact><gtr:outcomeId>BadiE85jxkG</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>497792</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Models of Disease Grant</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>400F6792-174E-486F-A136-CA286E1CCC6C</gtr:id><gtr:outcomeId>586F75DB7B00</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>Fight for Sight</gtr:fundingOrg><gtr:id>860A4FFF-F034-49CD-A082-2BA1ACC79997</gtr:id><gtr:outcomeId>caNLDRAB9tb</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>34390</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>The Special Trustees of Moorfields Eye Hospital General Fund</gtr:department><gtr:description>The Special Trustees of Moorfields Eye Hospital</gtr:description><gtr:end>2018-05-02</gtr:end><gtr:fundingOrg>Moorfields Eye Hospital NHS Foundation Trust</gtr:fundingOrg><gtr:id>C5E93F46-0D66-48D6-AF6C-44AD43543433</gtr:id><gtr:outcomeId>560a81b7dde708.03809633</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UCL BRCs - Francis Crick Institute Clinical Research Training Fellowship</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>Francis Crick Institute</gtr:fundingOrg><gtr:id>74119CA7-2D21-4A95-BC24-AC263605F728</gtr:id><gtr:outcomeId>560a804501ee99.71697265</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>new model to image tissue contraction in vitro live</gtr:description><gtr:id>B6770CCE-9984-448A-9D7F-793CE7E6663C</gtr:id><gtr:impact>identification of two phases in tissue contraction, improvement in the knowdledge of the basic molecular mechanisms of tissue contraction, development of better models for contraciton and scarring</gtr:impact><gtr:outcomeId>B0BC82704C7</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>new tissue contraction model</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>primary ocular fibroblast cell lines with different contraction abilities</gtr:description><gtr:id>88BFE400-6D74-45C5-A545-F6389764CC29</gtr:id><gtr:impact>better resources to study ocular tissue contraction</gtr:impact><gtr:outcomeId>49D5314D089</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>primary ocular fibroblast cell lines</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have develop a more physiological model to study tissue contraction using ex-vivo maintained conjunctiva</gtr:description><gtr:id>1D8322C7-8D95-4C4F-B491-23C0B26C2F2B</gtr:id><gtr:impact>the model is now published (in press) and will be available for all to use. We already have developed it further to test novel anti-scarring drugs</gtr:impact><gtr:outcomeId>ckHFjr6GV1d</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ex-vivo model of conjunctival tissue contraction</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>development of new imaging techniques to visualise matrix and cells live in 3D, as well as quantitate both the cell dynamic activity and the local tissue contraction</gtr:description><gtr:id>1FA8ECF6-C00D-49A1-B9BD-63F237718D97</gtr:id><gtr:impact>techniques now used by other groups to study scarring</gtr:impact><gtr:outcomeId>F4E9EA468C5</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>new imaging techniques</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>03026C66-2103-4B1F-B857-F143111F84DB</gtr:id><gtr:title>The molecular and functional phenotype of glomerular podocytes reveals key features of contractile smooth muscle cells.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Renal physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27b676a94efbdebd5ec821d522896233"><gtr:id>27b676a94efbdebd5ec821d522896233</gtr:id><gtr:otherNames>Saleem MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1522-1466</gtr:issn><gtr:outcomeId>sf71gZ66wzE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>774306D2-29AE-4F2D-B26F-7E16AEEAE255</gtr:id><gtr:title>Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97b274883a1e43c32b7d3477aca9ca99"><gtr:id>97b274883a1e43c32b7d3477aca9ca99</gtr:id><gtr:otherNames>Yu-Wai-Man C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5aa277d22426b9.62245301</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E34D062E-F2D7-4016-A037-0E06E14F966B</gtr:id><gtr:title>Independent adipogenic and contractile properties of fibroblasts in Graves' orbitopathy: an in vitro model for the evaluation of treatments.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08e3e9b152d63bb3495d9a000cd75f74"><gtr:id>08e3e9b152d63bb3495d9a000cd75f74</gtr:id><gtr:otherNames>Li H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54609b1c517ec5.70993434</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6969B0D4-8D0B-42AE-B847-C04EB290A237</gtr:id><gtr:title>Nuclear transport of the serum response factor coactivator MRTF-A is downregulated at tensional homeostasis.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf3869f6eeadab11c3db3605169de9f3"><gtr:id>bf3869f6eeadab11c3db3605169de9f3</gtr:id><gtr:otherNames>McGee KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>Yq92zoAYHAE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B663238-1D1B-40E6-B403-DA24ED477DD8</gtr:id><gtr:title>Changes in fibroblast mechanostat set point and mechanosensitivity: an adaptive response to mechanical stress in floppy eyelid syndrome.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/992951272fd0d9cd8c338e1cfd807dcf"><gtr:id>992951272fd0d9cd8c338e1cfd807dcf</gtr:id><gtr:otherNames>Ezra DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>i9uJaaJRQcC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFED64CA-1368-49AE-A7D3-096FC383B469</gtr:id><gtr:title>The role of the MRTF-A/SRF pathway in ocular fibrosis.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97b274883a1e43c32b7d3477aca9ca99"><gtr:id>97b274883a1e43c32b7d3477aca9ca99</gtr:id><gtr:otherNames>Yu-Wai-Man C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>54609b1c863227.56000376</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0500927</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>